Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

L Wollin, E Wex, A Pautsch, G Schnapp… - European …, 2015 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease characterised
by fibrosis of the lung parenchyma and loss of lung function. Although the pathogenic …

Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

…, IV Majoul, RT Strait, NL Harris, G Köhl, E Wex… - Nature medicine, 2012 - nature.com
Complement is an ancient danger-sensing system that contributes to host defense, immune
surveillance and homeostasis 1 . C5a and its G protein–coupled receptor mediate many of …

Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor

…, T Kiechle, D Seeliger, S Diehl, E Wex… - Journal of medicinal …, 2013 - ACS Publications
Antagonizing the human M3 muscarinic receptor (hM3R) over a long time is a key feature of
modern bronchodilating COPD drugs aiming at symptom relief. The long duration of action …

Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulation

MP Sanderson, E Wex, T Kono, K Uto, A Schnapp - Molecular Immunology, 2010 - Elsevier
Spleen tyrosine kinase (Syk) is a key regulatory factor in the IgE-mediated allergic signal
transduction pathway in mast cells and basophils. Syk is phosphorylated on a number of …

Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo

E Wex, T Bouyssou, MJ Duechs, KJ Erb… - European journal of …, 2011 - Wiley Online Library
The spleen tyrosine kinase (Syk) is a key mediator of immunoreceptor signaling in immune
cells. Thus, interfering with the function of Syk by genetic deletion or pharmacological …

BI 1002494, a novel potent and selective oral spleen tyrosine kinase inhibitor, displays differential potency in human basophils and B cells

…, T Bouyssou, B Guilliard, C Strasser, E Wex… - … of Pharmacology and …, 2016 - ASPET
BI 1002494 [(R)-4-{(R)-1-[7-(3,4,5-trimethoxy-phenyl)-[1,6]napthyridin-5-yloxy]-ethyl}pyrrolidin-2-one]
is a novel, potent, and selective spleen tyrosine kinase (SYK) inhibitor with …

Olodaterol shows anti‐fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis

…, J Wirth, F Gantner, B Lämmle, E Wex - British Journal of …, 2017 - Wiley Online Library
Background and Purpose Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease
characterized by excessive fibroblast activation ultimately leading to scarring of the lungs. …

The long‐acting β2‐adrenoceptor agonist olodaterol attenuates pulmonary inflammation

E Wex, I Kollak, MJ Duechs, E Naline… - British Journal of …, 2015 - Wiley Online Library
Background and Purpose β 2 ‐adrenoceptor agonists are widely used in the management
of obstructive airway diseases. Besides their bronchodilatory effect, several studies suggest …

[HTML][HTML] A novel model of IgE-mediated passive pulmonary anaphylaxis in rats

E Wex, E Thaler, S Blum, D Lamb - PLoS One, 2014 - journals.plos.org
Mast cells are central effector cells in allergic asthma and are augmented in the airways of
asthma patients. Attenuating mast cell degranulation and with it the early asthmatic response …

[HTML][HTML] Olodaterol attenuates citric acid-induced cough in naïve and ovalbumin-sensitized and challenged guinea pigs

E Wex, T Bouyssou - PLoS One, 2015 - journals.plos.org
Excessive coughing is a common feature of airway diseases. Different G-protein coupled
receptors, including β2-adrenergic receptors (β2-AR), have been implicated in the molecular …